000 01447 a2200373 4500
005 20250516231346.0
264 0 _c20160606
008 201606s 0 0 eng d
022 _a0946-1965
024 7 _a10.5414/CP202117
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacha, Sreeraj
245 0 0 _aPharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, and simvastatin following co-administration in healthy volunteers.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology and therapeutics
_cNov 2014
300 _a973-80 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBenzhydryl Compounds
_xadministration & dosage
650 0 4 _aCross-Over Studies
650 0 4 _aDrug Interactions
650 0 4 _aFemale
650 0 4 _aGlucosides
_xadministration & dosage
650 0 4 _aHealthy Volunteers
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSimvastatin
_xadministration & dosage
650 0 4 _aSodium-Glucose Transporter 2 Inhibitors
700 1 _aLang, Benjamin
700 1 _aPinnetti, Sabine
700 1 _aBroedl, Uli C
773 0 _tInternational journal of clinical pharmacology and therapeutics
_gvol. 52
_gno. 11
_gp. 973-80
856 4 0 _uhttps://doi.org/10.5414/CP202117
_zAvailable from publisher's website
999 _c24133997
_d24133997